Churchill Hospital

Oxford, England OX3 7LE

0 studies enrolling now · 3 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Multiple Myeloma, Myeloid Leukemia, Chronic, Chronic Phase

Studies at this site

• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
• Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients — Completed
• Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early